Jude Onyia
2021
In 2021, Jude Onyia earned a total compensation of $7.6M as Chief Scientific Officer at Neurocrine Biosciences.
Compensation breakdown
| Bonus | $26,170 |
|---|---|
| Option Awards | $4,500,035 |
| Salary | $52,340 |
| Stock Awards | $3,000,136 |
| Other | $2,949 |
| Total | $7,581,630 |
Onyia received $4.5M in option awards, accounting for 59% of the total pay in 2021.
Onyia also received $26.2K in bonus, $52.3K in salary, $3M in stock awards and $2.9K in other compensation.
Rankings
In 2021, Jude Onyia's compensation ranked 1,556th out of 12,415 executives tracked by ExecPay. In other words, Onyia earned more than 87.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,556 out of 12,415 | 88th |
Division Manufacturing | 568 out of 5,508 | 90th |
Major group Chemicals And Allied Products | 212 out of 2,378 | 91st |
Industry group Drugs | 177 out of 2,099 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 48 out of 449 | 89th |
Pay ratio
| Jude Onyia's Pay | $7,581,630 |
|---|---|
| Median Employee's Pay | $276,598 |
| Pay Ratio | 27to 1 |
In 2021, the annual total compensation of Jude Onyia was $7,581,630.
The annual total compensation of the median employee at Neurocrine Biosciences was $276,598.
The ratio of Jude Onyia's pay to the pay of median employee was therefore 27 to one.
Source: SEC filing on April 7, 2022.
Onyia's colleagues
We found four more compensation records of executives who worked with Jude Onyia at Neurocrine Biosciences in 2021.